Critical planning for regenerative medicine therapies needs to happen now to ensure smooth adoption into health system, paper urges
Data generation, evidence of clinical effectiveness, cost and social values among the key considerations
U of T and SickKids researchers demonstrate drug stimulation of neural stem cell repair leads to promising impact on treatment of childhood brain injury in survivors of brain cancer
Cross-species study shows that Type 2 diabetes drug metformin could change the way childhood brain injury is treated
Medicine by Design-funded team uses stem cells to grow functional blood vessel cells found in the liver
Discovery to provide insights into liver development and disease progression
Researchers delay onset of amyotrophic lateral sclerosis (ALS) in laboratory models
A team of researchers led by scientists at the University of Toronto has delayed the onset of amyotrophic lateral sclerosis (ALS) in mice. They are cautiously optimistic that this research, which was funded in part by a Medicine by Design 2018 New Ideas Award, combined with other clinical advances, points to a potential treatment for ALS in humans.
Genome editing just got more versatile thanks to a new technology developed by Medicine by Design-funded investigators at U of T
Scientists can now edit multiple sites in the genome at the same time to learn how different DNA stretches co-operate in health and disease.
Researchers develop first electrochemical platform for cell-free synthetic biology
'We think we can really accelerate the field and its capacity to improve lives'
A diabetes drug promotes brain repair — but only in females, U of T study shows
Accounting for sex differences could be key for the development of better treatments as drug shows promise for brain repair in females only
Medicine by Design-funded researchers devise new strategy to improve the safety of cell therapies
Finding inspiration from an unlikely source, a team led by Andras Nagy at Sinai Health System has an answer for one of the most pressing questions in cell therapy: how to ensure its safety
Medicine by Design researchers clear hurdles toward robust supply of stem cells for research and therapy
Paper identifies new combination of factors that allow scientists to grow stem cells in lab on much larger scale than previously possible
Engineered stem cell platform gives new insights into beginnings of human development
Medicine by Design-funded research could help answer fundamental biological questions and advance efforts to make organ-like structures
U of T research helps pave the way for an off-the-shelf supply of cells for immunotherapy
Researchers from Peter Zandstra's lab have developed new technologies that clear key barriers to developing a renewable source of cells for therapies.